PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-679.04%
Both yoy net incomes decline, with BRZE at -378.51%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-25.40%
Both reduce yoy D&A, with BRZE at -13.33%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-88.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
18305.81%
SBC growth well above BRZE's 436.72%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-72.37%
Both reduce yoy usage, with BRZE at -217.66%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-204.89%
Both yoy AR lines negative, with BRZE at -2827.89%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-2473.68%
Both reduce yoy inventory, with BRZE at -113.74%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
204.05%
AP growth well above BRZE's 401.39%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-41.32%
Negative yoy usage while BRZE is 1230.17%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
106.95%
Some yoy increase while BRZE is negative at -7.87%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-17.07%
Both yoy CFO lines are negative, with BRZE at -899.59%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-155.16%
Both yoy lines negative, with BRZE at -38.83%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-151.06%
Both yoy lines negative, with BRZE at -293.47%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-33.97%
We cut debt repayment yoy while BRZE is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Buyback growth of 100.00% while BRZE is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.